| Literature DB >> 33761344 |
Bas Brouwers1, Edson Mendes de Oliveira1, Maria Marti-Solano2, Fabiola B F Monteiro1, Suli-Anne Laurin3, Julia M Keogh1, Elana Henning1, Rebecca Bounds1, Carole A Daly4, Shane Houston4, Vikram Ayinampudi1, Natalia Wasiluk1, David Clarke1, Bianca Plouffe4, Michel Bouvier3, M Madan Babu5, I Sadaf Farooqi6, Jacek Mokrosiński1.
Abstract
The Melanocortin-4 Receptor (MC4R) plays a pivotal role in energy homeostasis. We used human MC4R mutations associated with an increased or decreased risk of obesity to dissect mechanisms that regulate MC4R function. Most obesity-associated mutations impair trafficking to the plasma membrane (PM), whereas obesity-protecting mutations either accelerate recycling to the PM or decrease internalization, resulting in enhanced signaling. MC4R mutations that do not affect canonical Gαs protein-mediated signaling, previously considered to be non-pathogenic, nonetheless disrupt agonist-induced internalization, β-arrestin recruitment, and/or coupling to Gαs, establishing their causal role in severe obesity. Structural mapping reveals ligand-accessible sites by which MC4R couples to effectors and residues involved in the homodimerization of MC4R, which is disrupted by multiple obesity-associated mutations. Human genetic studies reveal that endocytosis, intracellular trafficking, and homodimerization regulate MC4R function to a level that is physiologically relevant, supporting the development of chaperones, agonists, and allosteric modulators of MC4R for weight loss therapy.Entities:
Keywords: GPCRs; Gα(s); MC4R; MSH; melanocortin; obesity; therapy; weight loss; β-arrestin
Mesh:
Substances:
Year: 2021 PMID: 33761344 PMCID: PMC7994375 DOI: 10.1016/j.celrep.2021.108862
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423